Marksans Pharma has entered into a definitive agreement to acquire 100% of the share capital of ABCnow GmbH, a Germany based pharmaceutical company with frontend sales, marketing, and distribution capabilities across German healthcare market. The company will acquire entire shareholding of ABCnow GmbH for a total consideration of 892,384 euro. The acquisition is expected to be completed by July 31, 2026.
This acquisition will enable the company to use the front-end sales and marketing infrastructure of ABCnow GmbH for marketing its products manufactured in India, UK, and USA regions. It will bolster the company’s presence in the European markets.
The acquisition marks a strategic step in expanding the company’s presence across regulated European markets and strengthening its forward-integration strategy through direct, owned market-access capabilities in the European Union.
Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.
